Literature DB >> 47018

Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

P L Padfield, J J Brown, A F Lever, M A Schalekamp, D G Beevers, D L Davies, J I Robertson, M Tree.   

Abstract

A study of the frequency distribution of plasma-renin concentration in 81 patients with essential hypertension produced no evidence of a distinct sub-population with low renin levels. An arbitrary dividing line was used, therefore, to define low-renin hypertension (36% of patinets). Patients in this group were older than those with normal renin levels, and there was a significant negative correlation between renin and age among all patients. Low-renin hypertension was not characterized by increased exchangeable sodium, but exchaneable postassium was significantly lower than in patients with normal plasma-renin. This difference became insignificant when five patients in the low-renin group with persistent hypokalaemia were excluded. It is concluded that low-renin hypertension does not represent a separate diagnostic entity but that plasma-renin falls with age in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47018     DOI: 10.1016/s0140-6736(75)91559-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading.

Authors:  A Helber; G Wambach; W Hummerich; G Bönner; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1980-05-02

3.  Failure of methyclothiazide to lower home blood pressure level in "essential" hypertensive and normotensive young men, despite significant plasma volume contraction.

Authors:  R D Gordon; R H Mortimer; N Saar
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

4.  Acebutolol in hypertension--double-blind trial against placebo.

Authors:  M A Martin; C A Phillips; A J Smith
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

5.  Angiotensin II in essential hypertension.

Authors:  D G Beevers; J J Morton; C S Nelson; P L Padfield; M Titterington; M Tree
Journal:  Br Med J       Date:  1977-02-12

6.  Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.

Authors:  B I Hoffbrand; C J Edmonds; T Smith
Journal:  Br Med J       Date:  1976-03-20

7.  Age- and sex-related differences in plasma aldosterone in essential hypertension. Relationship to plasma renin activity.

Authors:  H Vetter; K Glänzer; I Alasso; W Vetter
Journal:  Klin Wochenschr       Date:  1979-05-03

Review 8.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

Review 9.  The renin-angiotensin-aldosterone system. Past, present and future.

Authors:  P Vecsei; E Hackenthal; D Ganten
Journal:  Klin Wochenschr       Date:  1978

10.  Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.

Authors:  F Skrabal; W Czaykowska; P Dittrich; H Braunsteiner
Journal:  Br Med J       Date:  1976-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.